Advancing Dronabinol Obstructive Sleep Apnea Program with Letter of Intent for Co-Development and Supply Agreement with Noramco, Inc.
19 juin 2018 08h45 HE
|
RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., June 19, 2018 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), is pleased to announce that on June 13, 2018, it entered into a letter...
Huneo Launches SnoreCoach™ Device and SnoreTrack™ App
01 août 2017 09h00 HE
|
Huneo
CLEVELAND, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Huneo, a biomedical data analytics company, announces the general availability of its SnoreCoach device. SnoreCoach was initially previewed in 2016 in a...